Prestroke proteomic changes in cerebral microvessels in stroke-prone, transgenic[hCETP]-hyperlipidemic, dahl salt- sensitive hypertensive rats

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 588-598

  Bergerat, Agnes ^a   Decano, Julius ^a   Wu, Chang Jiun ^b   Choi, Hyungwon ^c   Nesvizhskii, Alexey I ^c   Moran, Ann Marie ^a   Ruiz Opazo, Nelson ^a   Steffen, Martin ^a,d   Herrera, Victoria L M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; CARBONATE DEHYDRATASE IV; CHOLESTEROL ESTER TRANSFER PROTEIN; COLLAGEN TYPE 12; FILAMIN B; GLUCOSE TRANSPORTER 1; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT 12; K RAS PROTEIN; LAMININ ALPHA1; MEMBRANE PROTEIN; MICROSOMAL AMINOPEPTIDASE; NHE 3 REGULATOR 2; PYRUVIC ACID; SYNTROPHIN; TRANSFERRIN; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL INTERACTION; CELL MIGRATION; CITRIC ACID CYCLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DISEASE PREDISPOSITION; ENERGY METABOLISM; FEMALE; GENETIC HETEROGENEITY; GLUCONEOGENESIS; GLYCOLYSIS; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MALE; MICROVASCULATURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEOMICS; RAT; SEX DIFFERENCE; STROKE; TANDEM MASS SPECTROMETRY; TRANSGENE; TRANSLATIONAL RESEARCH;

ANIMALS; AQUAPORIN 4; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LAMININ; MALE; MICROVESSELS; PROTEOME; PROTEOMICS; RATS; RATS, INBRED DAHL; RATS, TRANSGENIC; STROKE; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 79960733740     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00228     Document Type: Article

References (51)

1. B. (2007) Prevention of stroke in patients with hypertension. Am. J. Cardiol. 100(Suppl): 17J-24J.
2. Endres M, et al. (2008) Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc. Dis. 25:268-78.
3. Hawkins BT, Davis TP. (2005) The blood brain barrier neurovascular unit in health and disease. Pharmacol. Rev. 37:173-85.
4. del Zoppo GJ, Milner R. (2006) Integrin-matrix interactions in the cerebral microvasculature. Arterioscler. Thromb. Vasc. Biol. 26:1966-75.
5. Lee SH, et al. (2004) Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology. 62:72-6.
6. Alemany M, Stenborg A, Terent A, Sonninen P, Raininko R. (2006) Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: correlation with signs of microangiopathy and clinical data. Radiology. 238:240-7.
7. Boulanger JM, et al. (2006) Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke. 37:911-4.
8. Decano JL, et al. (2009) Early-life sodium exposure unmasks susceptibility to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human cholesteryl ester transfer protein. Circulation. 119:1501-9.
9. Hamann GF, Okada Y, del Zoppo GJ. (1996) Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J. Cereb. Blood Flow Metab. 16:1373-8.
10. Rhodes JM, Simons M. (2007) The extracellular matrix and blood vessel formation: not just a scaffold. J. Cell Mol. Med. 11:176-205.
11. Wang CX, Shuaib A. (2007) Critical role of microvasculature basal lamina in ischemic brain injury. Prog. Neurology. 83:140-8.
12. Haqqani AS, et al. (2005) Characterization of vascular protein expression patterns in cerebral ischemia/ reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J. 19:1809-21.
13. Soreghan BA, et al. (2005) Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1+AâPP mouse model of Alzheimer's disease. J. Alzheimers Dis. 8:227-41.
14. Calabria AR, Shusta EV. (2006) Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery. Drug Discov. Today. 11:792-9.
15. del Zoppo GJ. (2010) The neurovascular unit in the setting of stroke. J. Intern. Med. 267:156-71.
16. Herrera VL, et al. (2004) Analysis of gender-specific atherosclerosis susceptibility in transgenic[hCETP]25DS rat model. Atherosclerosis. 177:9-18.
17. Song L, Pachter JS. (2003) Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cell. Dev. Biol. Anim. 39:313-20.
18. Ahmad QR, Nguyen DH, Wingerd MA, Church GM, Steffen MA. (2005) Molecular weight assessment of proteins in total proteome profiles using 1D-PAGE and LC/MS/MS. Proteome Sci. 3:6.
19. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. (2003) Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2:43-50.
20. Wu CJ, et al. (2009) A predictive phosphorylation signature of lung cancer. PlosOne. 4:e7994.
21. Kumar N, Wolf-Yadlin A, White FM, Lauffenburger DA. (2007) Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data. PLoS Comput. Biol. 3:e4.
22. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-50.
23. Choi H, Fermin D, Nesvizhskii AI. (2008) Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell. Proteomics. 7:2373-85.
24. Kass RE, Raftery AE. (1995) Bayes Factors. J. Am. Stat. Assoc. 90:773-95.
25. H. (1961) The Theory of Probability. Oxford University Press, 1961, p 432.
26. Ballabh P, Braun A, Nedergaard M. (2004) The blood brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16:1-13.
27. Agarwal N, Lippmann ES, Shusta EV. (2010) Identification and expression profiling of blood brain barrier membrane proteins. J. Neurochem. 112:625-35.
28. Liu H, Sadygov RG, Yates JR. (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76:4193-201.
29. Amiry-Moghaddam M, et al. (2004) Alpha syntrophin deletion removes the perivascular but not endothelial pool of aquaporin-4 at the blood brain barrier. FASEB J. 18:542-4.
30. Bolanos JP, Almeida A, Moncada S. (2010) Glycolysis: a bioenergetic or a survival pathway? Trends Biochem. Sci. 35:145-9.
31. Zlokovic BV. (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 57:178-201.
32. Verkman AS. (2009) Knock-out models reveal new aquaporin 4 functions. In E. Beitz (ed), Aquaporins, Handb. Exp Pharmacol. 190:359-81.
33. Nagelhus EA, Mathiisen TM, Ottersen OP. (2004) Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with Kir4.1. Neuroscience. 129:905-13.
34. Nicchia GP, et al. (2004) The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience. 129:935-45.
35. Tomassoni D, Bramanti V, Amenta F. (2010) Expression of aquaporins 1 and 4 in the brain of spontaneously hypertensive rats. Brain Res. 1325:155-63.
36. Aoki K, et al. (2003) Enhanced expression of aquaporin 4 in human brain with infarction. Acta. Neuropathol. 106:121-4.
37. Bufa FM, Harris AL, West CM, Miller CJ. (2010) Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br. J. Cancer. 102:428-35.
38. Gavard J, Gutkind JS. (2008) Protein kinase Crelated kinase and ROCK are required for thrombin- induced endothelial cell permeability downstream from Galpha12/13 and Galpha11/q. Biol. Chem. 283:29888-96.
39. Jin X, et al. (2003) Shear stress-induced collagen XII expression is associated with atherogenesis. Biochem. Biophys. Res. Commun. 308:152-8.
40. Nogradi A, et al. (2003) Up-regulation of cerebral carbonic anhydrase by anoxic stress in piglets. J. Neurochem. 85:843-50.
41. Shah GN, et al. (2005) Carbonic anhydrase IV and XIV knockout mice: roles of the respective carbonic anhydrases in buffering the extracellular space in brain. Proc. Natl. Acad. Sci. U. S. A. 102:16771-6.
42. Jung Kang Y, et al. (2004) NHERF2 increases platelet-derived growth factor-induced proliferation through PI-3-kinase/Akt-, and Src family kinase- dependent pathway. Cell. Signal. 16:791-800.
43. Thiesen CS, Wahl JK 3rd, Johnson KR, Wheelock MJ. (2007) NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility. Mol. Biol. Cell. 18:1220-32.
44. Terwaki S, Maesaki R, Hakoshima T. (2006) Structural basis for NHERF recognition by ERM proteins. Structure. 14:777-89.
45. Rangel R, et al. (2007) Impaired angiogenesis in aminopeptidase N-null mice. Proc. Natl. Acad. Sci. U. S. A. 104:4588-93.
46. Zeng M, Kikuchi H, Pino MS, Chung DC. (2010) Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoSOne 5(6):e10966.
47. Del Valle-Perez B, et al. (2010) Filamin B plays a key role in VEGF-induced endothelial cell motility through its interaction with Rac-1 and Vav-2. J. Biol. Chem. 285:10748-60.
48. Kanters E, et al. (2008) Filamin B mediates ICAM-1-driven leukocyte transendothelial migration. J. Biol. Chem. 283:31830-9.
49. Moos T, Morgan EH. (2004) The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. N.Y. Acad. Sci. 1012:14-26.
50. van Campenhout A, van Campenhout CM, Lagrou AR, Manuel-Y-Keenov B. (2007) Transferrin modifications and lipid peroxidation: implications in diabetes mellitus. Free Radic. Res. 37:1069-77.
51. Ponce ML, Kleinman HK. (2003) Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp. Cell Res. 285:189-95.